Welcome to Prof. Junho Chung's Laboratory
We Innovate the technologies for developing therapeutic antibodies and related bio-pharmaceuticals including chimeric antigen T cell receptor (CAR) T cell therapy and antibody drug conjugate.
We also Develop novel therapeutic antibodies tackling human disease by ourselves. For example, a hepatocyte growth factor (HGF)-neutralizing antibody (YYB101 OR NOV1105, nov.ncc.re.kr/eng/) had successfully finished phase I clinical trial (ClinicalTrials.gov Identifier: NCT02499224) and entered phase II clinical trial. A few more antibodies are under pre-clinical development.
We Create the algorithm for deciphering B cell repertoire of human and model animals using Machine learning and Next Generation Sequencing (NGS) technology. This research provides the clues on the pathogenesis of autoimmune disease and immunological response to carcinogenesis.
Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine
Department of Biomedical Sciences, Seoul National University College of Medicine
Laboratory of Antibody Engineering, Cancer Research Institute, Seoul National University
Suites 506-515, Samsung Cancer Research Building
Daehakro 103, Seoul 03080, South Korea (Rep. of Korea)
Last Update: 29 Oct 2019